Akorn Inc. Opens First International Office
Dr. Sonavaria will be responsible for quality, cGMP and CFR compliance and regulatory affairs for the pipeline of new ANDA products, which the company expects to market as a result of agreements with Serum, FDC Limited and Strides Arcolab Limited.
Since 2004, Dr. Sonavaria was Director, Product Development, R&D for Sicor Pharmaceuticals Inc., where she provided leadership and technical support for the company's parenteral, biological and oncolytic ANDA submissions. From 2000 to 2004, she served as Associate Director, Product Development, R&D at Sicor.
From 1997 to 2000, Dr. Sonavaria served as Principal Scientist at American Pharmaceutical Partners (then Fujisawa USA, Inc.), where she led multiple projects related to the scale up and manufacture of stability and validation batches for new products. She joined Fujisawa as Senior Scientist in 1994.
Dr. Sonavaria holds both a Ph.D., and M.S., in Pharmaceutical Sciences and Industrial Pharmacy from Massachusetts College of Pharmacy, Boston, and a B.B. in Pharmacy from C.U. Shah College of Pharmacy, Bombay, India.
Most read news
Organizations
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.